SU576898A3 - Способ снижени реактогенности гамма-глобулина - Google Patents

Способ снижени реактогенности гамма-глобулина

Info

Publication number
SU576898A3
SU576898A3 SU7502306354A SU2306354A SU576898A3 SU 576898 A3 SU576898 A3 SU 576898A3 SU 7502306354 A SU7502306354 A SU 7502306354A SU 2306354 A SU2306354 A SU 2306354A SU 576898 A3 SU576898 A3 SU 576898A3
Authority
SU
USSR - Soviet Union
Prior art keywords
globulin
gamma
reducing
reactogenesis
precipitate
Prior art date
Application number
SU7502306354A
Other languages
English (en)
Russian (ru)
Inventor
Шнайдер Вальдемар
Вольтер Дитрих
Original Assignee
Ратиофарма Анштальт Лихтенштейн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ратиофарма Анштальт Лихтенштейн (Фирма) filed Critical Ратиофарма Анштальт Лихтенштейн (Фирма)
Application granted granted Critical
Publication of SU576898A3 publication Critical patent/SU576898A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SU7502306354A 1975-01-02 1975-12-31 Способ снижени реактогенности гамма-глобулина SU576898A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
SU576898A3 true SU576898A3 (ru) 1977-10-15

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
SU7502306354A SU576898A3 (ru) 1975-01-02 1975-12-31 Способ снижени реактогенности гамма-глобулина

Country Status (20)

Country Link
JP (1) JPS5512001B2 (sv)
AT (1) AT344883B (sv)
AU (1) AU505416B2 (sv)
BE (1) BE837211A (sv)
CA (1) CA1058075A (sv)
DD (1) DD121875A5 (sv)
DE (1) DE2500076C3 (sv)
DK (1) DK144679C (sv)
EG (1) EG11987A (sv)
ES (1) ES443982A1 (sv)
FR (1) FR2296429A1 (sv)
GB (1) GB1495159A (sv)
IE (1) IE43449B1 (sv)
IL (1) IL48766A (sv)
IN (1) IN143525B (sv)
NL (1) NL179824C (sv)
PL (1) PL99599B1 (sv)
SE (1) SE437470B (sv)
SU (1) SU576898A3 (sv)
ZA (1) ZA758050B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
IL297746A (en) 2005-11-30 2022-12-01 Abbvie Inc Monoclonal antibodies against amyloid beta protein and uses thereof
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (sv) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (sv) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
DD121875A5 (sv) 1976-09-05
NL179824B (nl) 1986-06-16
PL99599B1 (pl) 1978-07-31
IE43449L (en) 1976-07-02
DE2500076C3 (de) 1982-11-18
ZA758050B (en) 1976-12-29
DE2500076B2 (de) 1979-02-22
EG11987A (en) 1981-12-31
ES443982A1 (es) 1977-07-16
SE7514388L (sv) 1976-07-05
GB1495159A (en) 1977-12-14
AT344883B (de) 1978-08-10
IL48766A0 (en) 1976-02-29
DK144679B (da) 1982-05-10
DK144679C (da) 1982-10-11
IN143525B (sv) 1977-12-17
BE837211A (fr) 1976-06-30
FR2296429B1 (sv) 1978-12-01
DK584375A (da) 1976-07-03
IE43449B1 (en) 1981-02-25
SE437470B (sv) 1985-03-04
JPS5512001B2 (en) 1980-03-29
AU505416B2 (en) 1979-11-22
FR2296429A1 (fr) 1976-07-30
JPS5191321A (en) 1976-08-10
DE2500076A1 (de) 1976-07-08
IL48766A (en) 1979-11-30
CA1058075A (en) 1979-07-10
AU8792175A (en) 1977-07-14
NL179824C (nl) 1986-11-17
ATA981675A (de) 1977-12-15
NL7514627A (nl) 1976-07-06

Similar Documents

Publication Publication Date Title
SU576898A3 (ru) Способ снижени реактогенности гамма-глобулина
Börjeson et al. STUDIES ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO: I. BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES OF THE POKEWEED MITOGEN
Van der Geld et al. Reactivity of Myasthenia Gravis Serum γ-Globulin with Skeletal Muscle and Thymus Demonstrated by Immunofluoirescence.
FR2372841A1 (fr) Gamma-globuline injectable par voie intraveineuse
EA199700143A1 (ru) Способ и композиция ждя липидизации гидрофильных молекул
Preer Jr Studies on the Immobilization Antigens of Paramecium: II. Isolation
Kodama et al. Plane xanthomatosis with antilipoprotein autoantibody
ATE1288T1 (de) Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
SU638243A3 (ru) Способ очистки гамма- -глутамилтаурина
GB779493A (en) Process for the isolation of stable, highly purified gamma globulin preparations
Rimington et al. Comparison of the globoglycoid, crystalbumin, seroglycoid and seromucoid fractions of normal horse serum
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
Sehon et al. Physico-chemical and immunologic studies on macroglobulins
GB1476103A (en) Method for the separation of chlorophyll
Serra Cytochemical demonstration of masked lipids
Ekramoddoullah et al. Isolation of allergenically active cytochrome c from Kentucky blue grass pollen
McCasland et al. Synthesis of Sulfur Analogs of Inositol (Dimercaptocyclohexanetetrols). Nuclear Magnetic Resonance Configurational Proofs1, 2
Svec et al. A variant LE cell factor reactive only with “altered” nuclear material
CN104479005B (zh) 一种促性腺激素纯化的方法
SU642331A1 (ru) Композици дл получени пленок
Devlin et al. Association of acute local reactions to insulin with an insulin-binding gamma IM antibody
ES416726A1 (es) Procedimiento para aislar un antigeno de polipeptido aso- ciado con el cancer.
ROBBOY et al. Zone electrophoresis and prolactin activity of rat adenohypophysis cultivated in vitro
Maas et al. A method for selective staining of damaged yeast cells
Cassuto et al. Mycosis fungoides associated with Mediterranean lymphoma